|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||2.3400 - 2.6560|
|52 Week Range||1.7440 - 4.7500|
|Beta (5Y Monthly)||1.25|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MONTREAL, March 8, 2021 /CNW Telbec/ - Laurent Marchand, founding President and CEO of KaloomTM, is pleased to announce that an agreement in principle, subject to various conditions, has been reached on a change of control transaction led by the management of the Company, in partnership with Alternative Capital Group Inc. The change of control transaction is planned to close, if all conditions are met, on April 22nd, 2021.
TORONTO, ON / ACCESSWIRE / February 23, 2021 / Kontrol Technologies Corp. (CSE:KNR) (OTCQB:KNRLF) (FSE:1K8) ("Kontrol Technologies" or "Kontrol" or "Company") is pleased to announce that it plans to provide real-time demonstration of BioCloud units in operation in various customer and/or pilot customer ("customer") applications.
Advanced technologies and applications such as point-of-care, pediatrics, dry-magnets, compact MRI and fusion imaging are driving global marketSANTA CLARA, Calif. 22, 2021 /CNW/ -- Frost & Sullivan's recent analysis, Technological Advancements and Emerging Applications in the Global Magnetic Resonance Imaging (MRI) Market, Forecast to 2024, finds that the MRI market is diversifying with momentum in the privatization trend.